Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
Thomas Payne, Matthew Appleby, Ellen Buckley, et al.
Movement Disorders (2023) Vol. 38, Iss. 8, pp. 1493-1502
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 231
Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Eman E. Alshial, Muhammad Idris Abdulghaney, Al-Hassan Soliman Wadan, et al.
Life Sciences (2023) Vol. 334, pp. 122257-122257
Closed Access | Times Cited: 48
Targeting mitophagy in neurodegenerative diseases
Odetta Antico, Paul Thompson, Nicholas T. Hertz, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 6
The Potential Role of Mitochondria in the Microbiota-Gut-Brain Axis: Implications for Brain Health
Lei Qiao, Ge Yang, Peng Wang, et al.
Pharmacological Research (2024) Vol. 209, pp. 107434-107434
Open Access | Times Cited: 10
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access | Times Cited: 1
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Nirosen Vijiaratnam, Thomas Foltynie
Brain (2023) Vol. 146, Iss. 12, pp. 4845-4869
Open Access | Times Cited: 21
Unveiling the gut-eye axis: how microbial metabolites influence ocular health and disease
Yvonne Nguyen, Josephine Rudd Zhong Manis, Nicole M. Ronczkowski, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 6
Pharmacotherapy for Disease Modification in Early Parkinson’s Disease: How Early Should We Be?
Philipp Mahlknecht, Werner Poewe
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S407-S421
Open Access | Times Cited: 4
Disease-Modifying Therapies in Parkinson’s Disease
Margherita Fabbri, Jean‐Christophe Corvol, Olivier Rascol
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 319-340
Closed Access
The effects of ursodeoxycholic acid on Parkinson’s disease, a mechanistic review of the recent evidence
Seyed Mehrad Razavi, Niusha Esmaealzadeh, Mahshid Ataei, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 2
Closed Access
Mitochondrial Dysfunction, Genetic Predisposition, and Targeted Interventions in Neurodegenerative Diseases and Cognitive Decline: A Meta-Analysis of Mechanisms and Treatments
Sher Bano, Sonam Lohana, Harsha Sai Krishna Gottimukkala, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 3, pp. 1-8
Closed Access
α-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease
Yakum B Mingo, Martha L. Escobar Galvis, Michael X. Henderson
Neurobiology of Disease (2025), pp. 106889-106889
Open Access
HDCA Alleviates Parkinson's Disease Symptoms by Promoting Autophagic Degradation of α-synuclein in enteric neurons
Rui Kong, Jinbao Zhang, Miao Xu, et al.
Phytomedicine (2025) Vol. 142, pp. 156749-156749
Closed Access
The Role of Microbial Metabolites in the Progression of Neurodegenerative Diseases—Therapeutic Approaches: A Comprehensive Review
Jorge Missiego-Beltrán, Ana Isabel Beltrán-Velasco
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10041-10041
Open Access | Times Cited: 3
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative
Richard Wyse, Tom Isaacs, Roger A. Barker, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 4, pp. 657-666
Open Access | Times Cited: 2
Emerging Roles of Bile Acids and TGR5 in the Central Nervous System: Molecular Functions and Therapeutic Implications
Lorenzo Romero‐Ramírez, Jörg Mey
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9279-9279
Open Access | Times Cited: 2
The liver–brain axis in metabolic dysfunction-associated steatotic liver disease
Anne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard, Anthony H.V. Schapira, et al.
˜The œLancet. Gastroenterology & hepatology (2024)
Closed Access | Times Cited: 2
Review on chronic metabolic diseases surrounding bile acids and gut microbiota: What we have explored so far
Zhenzheng Zhu, Yuemiao Xu, Yuwei Xia, et al.
Life Sciences (2023) Vol. 336, pp. 122304-122304
Open Access | Times Cited: 6
Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease
Meng‐Fan Yao, Tao Dang, Huajun Wang, et al.
Behavioural Brain Research (2023) Vol. 459, pp. 114811-114811
Open Access | Times Cited: 5
Polygenic Risk Scores Validated in Patient‐Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease
Giuseppe Arena, Zied Landoulsi, Dajana Großmann, et al.
Annals of Neurology (2024) Vol. 96, Iss. 1, pp. 133-149
Open Access | Times Cited: 1
Objective Monitoring of Motor Symptom Severity and their Progression in Parkinson’s Disease Using a Digital Gait Device
Tamara Raschka, Jackrite To, Tom Hähnel, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson’s Disease
Xiaoqin He, Yiqiu Lai, Chengjun Mo, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1432-1432
Open Access | Times Cited: 1
Protective effect of UDCA against IL-11- induced cardiac fibrosis is mediated by TGR5 signalling
Benedict Reilly-O’Donnell, Elisa Ferraro, Roman Tikhomirov, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Investigation of the causal relationship between cholelithiasis and Parkinson's disease: A bidirectional Mendelian randomization study
Zijiao Yang, Chengfu Song, Chong Lu
Health Science Reports (2024) Vol. 7, Iss. 10
Open Access
NMR in living systems
M. J. W. Prior
Royal Society of Chemistry eBooks (2024), pp. 231-269
Closed Access
Page 1 - Next Page

Scroll to top